Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
11.11
+0.09 (0.82%)
At close: Jul 11, 2025, 4:00 PM
11.50
+0.39 (3.51%)
After-hours: Jul 11, 2025, 7:57 PM EDT
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $1.39 billion as of July 11, 2025. Its market cap has increased by 103.16% in one year.
Market Cap
1.39B
Enterprise Value
1.48B
1-Year Change
103.16%
Ranking
Category
Stock Price
$11.11
Market Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $1.39B, an increase of 134.25%. That is a compound annual growth rate of 9.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 1.28B | -43.36% |
| Dec 31, 2024 | 2.26B | 1,162.26% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.79B |
| Johnson & Johnson | 379.41B |
| AbbVie | 344.45B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 271.70B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 223.49B |